Mostrando entradas con la etiqueta Farmacoseguridad Extrínseca. Mostrar todas las entradas
Mostrando entradas con la etiqueta Farmacoseguridad Extrínseca. Mostrar todas las entradas

Improving patient safety through medicine risk communication: a theory-informed evaluation approach

AI and machine learning for predicting in vitro/preclinical drug toxicities and adverse events in clinical patients

How Machine Learning Can Help Close Evidence Gaps for Drug Safety in Pregnant Women

Interpol alerta del auge de antiparasitarios veterinarios promovidos como tratamientos contra el cáncer en humanos

Deviations from recommended use of liposomal bupivacaine: a real-world pharmacovigilance study using the FAERS database

Knowledge Graph for Cardiovascular Drug Safety and Pharmacovigilance: A Scoping Review

79th World Health Assembly adopts resolution to strengthen pharmacovigilance

Adverse Drug Reaction Costs and Study Quality in Africa: A Systematic Review of Cost-of-Illness Studies

Quality of adverse drug reaction reports submitted to the national pharmacovigilance center of Nepal: a pre-and post-training evaluation

WHO and African Medicines Agency launch landmark framework to strengthen access to quality-assured health products in Africa

The High Stakes of Pharmacovigilance: Why Specialized Partnership Outperforms the Large CRO Model

Counterfeit anti-rabies vaccine as a neglected issue: a manufacturers’ perspective

Knowledge, attitude, and practice of undergraduate medical students toward pharmacovigilance and adverse drug reaction reporting: A questionnaire-based study

Turning the tide on substandard and falsified medicines – the Medicine Quality, Innovation & Policy Conference, April 2026

How the VMD monitors the safety of animal medicines

Antibiotic Stewardship: Five Tips to Reduce Resistance